Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease

by Emma Hockly, Jamie Tse, Amy L. Barker, Donna L. Moolman, Jean-Luc Beunard, Adrian P. Revington, Kim Holt, Sunny Sunshine, Hilary Moffitt, Kirupa Sathasivam, Benjamin Woodman, Erich E. Wanker, Philip A.S. Lowden, Gillian P. Bates
Published 2006-01-01